Results 201 to 210 of about 27,115 (215)

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Ca-A Cancer Journal for Clinicians
Yan Yu, Diansheng Zhong, Lin Wu
exaly  

Targeting the EGFR signaling pathway in cancer therapy

Expert Opinion on Therapeutic Targets, 2012
Moorthy Palanimuthu Ponnusamy, Surinder K Batra, Maneesh Jain   +2 more
exaly  

Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions

Annals of Oncology, 2018
Daniel B Costa, J F Gainor, L V Sequist
exaly  

EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Cancer Cell
Joaquín Araos, Giulia Biffi
exaly  

EGFR mutations

2009
openaire   +12 more sources

EGFR

openaire   +1 more source

EGFR-binding peptide

2014
IIMORI YUSUKE, YAMAGATA MIZUE, SHIONO TOMOTAKA   +2 more
openaire   +5 more sources

EGFR-BASED PEPTIDES

2012
SCHROEDER JOYCE A, BITLER BENJAMIN G, GOVERDHAN AARTHI   +2 more
openaire   +3 more sources

HUMANIZED EGFR ANTIBODIES

2012
GOLETZ STEFFEN, DANIELCZYK ANTJE
openaire   +4 more sources

A Novel EGFR Variant

2014
SKOG JOHAN KARL OLOV, BERGHOFF EMILY, LOGUIDICE LORI   +2 more
openaire   +3 more sources